Breast Cancer Recurrence Risk Varies by Molecular Subtype
Different molecular subtypes of breast cancer had varying rates and patterns of recurrence following surgery for early-stage disease, a large retrospective cohort study showed. Overall, the 10-year freedom from ipsilateral, regional, and contralateral recurrence was 95.9%, 96.1%, and 96.5%, respectively. Using hormone receptor (HR)-positive (+)/HER2-negative (-) tumors as the reference, HR-/HER2+ breast cancer had the […]
When Is ADT Right for Biochemically Recurrent Prostate Cancer?
Men with prostate cancer and biochemical recurrence (BCR) who delayed androgen deprivation therapy (ADT) still experienced long survival outcomes, researchers reported. In a retrospective study, men with a prostate-specific antigen doubling time (PSADT) of less than 10 months saw a median metastases-free survival (MFS) of 192 months when they delayed ADT until metastasis, and a […]